(Q54043857)

24 May 2018

title

Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. (English)

1 reference

24 May 2018

0 references

1

1 reference

24 May 2018

author name string

Nielsen KG

series ordinal

2

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

24 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

24 May 2018

volume

162

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

187-190

1 reference

24 May 2018

A review of pulmonary function testing in children

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Lung function measurement in awake young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Measurement of the specific airway resistance by plethysmography in young children accompanied by an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Lung function response to cold air challenge in asthmatic and healthy children of 2-5 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Exercise-induced asthma. Assessment of current etiologic concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Inhaled budesonide for treatment of recurrent wheezing in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Use of budesonide in severe asthmatics aged 1-3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

Lung function and short-term outcome in young asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.162.1.9910039

10.1164/AJRCCM.162.1.9910039

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10903240

1 reference

24 May 2018